Literature DB >> 12967586

Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats.

A Akula1, M K Kota, S G Gopisetty, R V Chitrapu, M Kalagara, S Kalagara, K K Veeravalli, J P Gomedhikam.   

Abstract

Diabetes mellitus is associated with an increased susceptibility to cardiovascular disease and it has been suggested that alterations in myocardial function may contribute to the development of diabetic cardiovascular complications. The objective of the present study is to examine the left ventricular (LV) function in streptozotocin (STZ)-induced diabetic rats in a definite course of time by non-invasive methods, i.e. M-mode and Doppler echocardiography. From the results, it was found that treatment of animals with STZ resulted in increase in blood glucose, triglycerides, cholesterol, low density lipoproteins (LDL) and decrease in serum total protein levels. Echocardiographic studies revealed that LV internal dimension (mm) during systole was significantly increased after 12 weeks of diabetes when compared to base line data of the same animals and with control animals 6.50+/-0.13 versus 4.25+/-0.17, versus 4.34+/-0.25 (P<0.05), however there was no significant change after 4-8 weeks of diabetes. Also LV internal dimension (mm) during end diastole increased significantly only after 12 weeks of diabetes than to base line data of the same animals and with control animals 7.71+/-0.34 versus 6.18+/-0.25, versus 6.25+/-0.18 (P<0.05). Fractional shortening (%), 15.69+/-5.1 versus 31.22+/-1.7, versus 30.56+/-2.1 (P<0.05), and ejection fraction (%) 37+/-2.31 versus 68.18+/-2.8, versus 60.32+/-3.5 (P<0.05), differ significantly after 12 weeks of diabetes when compared to base line data of the same animals and with control animals. E-wave (cm/s) was significantly decreased after 12 weeks of diabetes 21.11+/-1.5 versus 35.19+/-4.5, versus 32.75+/-3.0 (P<0.05), and A-wave (cm/s) was significantly increased after 12 weeks of diabetes 34.88+/-4.2 versus 19.21+/-2.8, versus 20.59+/-2.1 (P<0.05); thus, diabetic animals after 12 weeks had an inversed E/A ratio. Histological studies revealed that after 8 weeks of diabetes, necrosis was minimal, but after 12 weeks of diabetes extensive focal endomyocardial necrosis was observed. From this study, we conclude that overt LV systolic and diastolic dysfunction was fully visible at 12 weeks of diabetes on echocardiography and this non-invasive technique of echocardiography is useful in diagnosing LV dysfunction in diabetic rats without the need of invasive histopathological procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967586     DOI: 10.1016/s1043-6618(03)00191-9

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  21 in total

1.  Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.

Authors:  G de Simone; R B Devereux; M J Roman; M Chinali; A Barac; J A Panza; E T Lee; J M Galloway; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-09-21       Impact factor: 4.222

2.  Effects of the association of diabetes and pulmonary emphysema on cardiac structure and function in rats.

Authors:  Antonio Di Petta; Rafael Simas; Clebson L Ferreira; Vera L Capelozzi; Vera M C Salemi; Luiz F P Moreira; Paulina Sannomiya
Journal:  Int J Exp Pathol       Date:  2015-10-29       Impact factor: 1.925

3.  The mitochondrial permeability transition pore and the cardiac necrotic program.

Authors:  Christopher P Baines
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

4.  Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.

Authors:  Véronique A Lacombe; Serge Viatchenko-Karpinski; Dmitry Terentyev; Arun Sridhar; Sitaramesh Emani; John D Bonagura; David S Feldman; Sandor Györke; Cynthia A Carnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-29       Impact factor: 3.619

5.  Previous exercise training has a beneficial effect on renal and cardiovascular function in a model of diabetes.

Authors:  Kleiton Augusto dos Santos Silva; Rafael da Silva Luiz; Rodolfo Rosseto Rampaso; Nayda Parísio de Abreu; Édson Dias Moreira; Cristiano Teixeira Mostarda; Kátia De Angelis; Vicente de Paulo Castro Teixeira; Maria Cláudia Irigoyen; Nestor Schor
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  Cardioprotective Activity of Pongamia pinnata in Streptozotocin-Nicotinamide Induced Diabetic Rats.

Authors:  Sachin L Badole; Swapnil M Chaudhari; Ganesh B Jangam; Amit D Kandhare; Subhash L Bodhankar
Journal:  Biomed Res Int       Date:  2015-04-14       Impact factor: 3.411

7.  Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging.

Authors:  Can Qian; Li Gong; Zunyuan Yang; Wei Chen; Yushu Chen; Ziqian Xu; Bing Wu; Chungui Tang; Fabao Gao; Wen Zeng
Journal:  BMC Cardiovasc Disord       Date:  2015-06-26       Impact factor: 2.298

8.  Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents.

Authors:  Rogério Wichi; Christiane Malfitano; Kaleizu Rosa; Silvia B De Souza; Vera Salemi; Cristiano Mostarda; Kátia De Angelis; Maria Claudia Irigoyen
Journal:  Cardiovasc Diabetol       Date:  2007-04-26       Impact factor: 9.951

9.  Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study.

Authors:  Bernard Cosyns; Steven Droogmans; Caroline Weytjens; Tony Lahoutte; Guy Van Camp; Danny Schoors; Philippe R Franken
Journal:  Cardiovasc Diabetol       Date:  2007-10-15       Impact factor: 9.951

10.  Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats.

Authors:  Bernard Cosyns; Steven Droogmans; Sophie Hernot; Céline Degaillier; Christian Garbar; Caroline Weytjens; Bram Roosens; Danny Schoors; Tony Lahoutte; Philippe R Franken; Guy Van Camp
Journal:  Cardiovasc Diabetol       Date:  2008-09-02       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.